Andrew Durand advises private and public companies of all growth stages on a wide range of corporate matters, including IPOs, public offerings, acquisition financings and mergers and acquisitions.

Download full bio 


  • Olink Holding – $406 Million IPO 

  • AvePoint to Combine With Apex Technology, a Special Purpose Acquisition Company, at $2 Billion Value 

  • Landos Biopharma – $100 Million IPO 

  • Pharmapacks $150 Million Growth Financing 

  • PolyPid – $69 Million IPO 

  • View all


  • University of Chicago Law School
    JD, 2019

  • Whitman College
    BA, Rhetoric

Admissions & Credentials

District of Columbia